Chronic Kidney Disease Trial, Recruiting NCT05489120 Sponsor: Dr. Schär AG / SPA Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT05489120
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have chronic kidney disease (CKD) at a moderate to severe stage (stages 3a to 5), with kidney function below a certain level, and who are not currently on dialysis
  • People who have a good nutritional status — meaning no signs of malnutrition based on blood tests and body weight measurements
  • People who are currently eating more than 1 gram of protein per kilogram of their ideal body weight each day
  • People who have never previously followed a low-protein diet
  • People who are willing to change their eating habits and follow dietary guidance throughout the trial
  • People who are able to attend all scheduled trial visits and complete diet records and questionnaires
  • People who are covered by a health insurance system in France
  • People who have given written consent to take part in the trial

Who may not be able to join:

  • People for whom dialysis or a kidney transplant is planned or expected within the next 12 months
  • People with a known allergy to ingredients found in FLAVIS products, including milk, eggs, soy, or nuts
  • People with poorly controlled diabetes (based on a specific blood sugar measure called HbA1c being above 8.5%)
  • People with an active cancer diagnosis, including those who have been in remission for fewer than 5 years
  • People with psychiatric conditions or any other reason that would make it difficult to follow the trial requirements
  • People with an active infection or an inflammatory disease that is not well controlled
  • People who are unable to give blood samples due to poor vein access
  • People who are unable to correctly collect a full 24-hour urine sample
  • People who have had a change in their regular medications within one month before the screening visit
  • People who have any significant medical condition or history that the trial doctor believes could affect safety, results, or participation
  • People who have an active implanted medical device (such as a pacemaker) (confirm with trial site)
  • People who are currently participating in another clinical trial, or who are still within a waiting period following a previous clinical trial
  • Certain groups of people considered vulnerable under French public health law are also excluded (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laetitia Koppe, Dr, HCL

Phone: 0756917356

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dr. Schär AG / SPA
Registry
ClinicalTrials.gov
Start date
6 November 2022
Est. completion
1 March 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Effectiveness in terms of protein intake of a LPD with LP foods (FLAVIS products) compared to standard products (LPD without consumption of LP foods)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov